Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam S Duerfeldt

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
International Journal of Molecular Sciences|December 9, 2020
Small-Molecule Modulation of PPARs for the Treatment of Prevalent Vascular Retinal DiseasesXiaozheng Dou, Adam S Duerfeldt
Chemmedchem|November 18, 2025
Development and Characterization of a Noncovalent Stimulator of Interferon Genes Proteolysis-Targeting ChimerasBo Hu, Adam S Duerfeldt
Journal of the American Chemical Society|January 14, 2014
Total syntheses of (-)-pyrimidoblamic acid and P-3AAdam S Duerfeldt, Dale L Boger
Journal of Medicinal Chemistry|December 22, 2023
Guiding the Way: Traditional Medicinal Chemistry Inspiration for Rational Gram-Negative Drug DesignAlexis M Stoorza, Adam S Duerfeldt
Bioorganic & Medicinal Chemistry Letters|July 27, 2010
Hsp90 inhibition: elimination of shock and stressAdam S Duerfeldt, Brian S J Blagg
ACS Chemical Biology|April 18, 2009
Hydrating for resistance to radicicolAdam S Duerfeldt, Brian S J Blagg
Future Medicinal Chemistry|May 11, 2023
The cGAS-STING pathway in diabetic retinopathy and age-related macular degenerationBo Hu, Jian-Xing Ma, Adam S Duerfeldt
Bioorganic & Medicinal Chemistry Letters|October 22, 2011
Synthesis and biological evaluation of arylated novobiocin analogs as Hsp90 inhibitorsBhaskar Reddy Kusuma, Adam S Duerfeldt, Brian S J Blagg
Bioorganic & Medicinal Chemistry Letters|November 10, 2009
Design, synthesis, and biological activity of bicyclic radester analogues as Hsp90 inhibitorsVinod D Jadhav, Adam S Duerfeldt, Brian S J Blagg
ACS Infectious Diseases|November 10, 2018
Clostridium difficile ClpP Homologues are Capable of Uncoupled Activity and Exhibit Different Levels of Susceptibility to Acyldepsipeptide ModulationNathan P Lavey, Tyler Shadid, Jimmy D Ballard, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
International Journal of Molecular Sciences|December 9, 2020
Small-Molecule Modulation of PPARs for the Treatment of Prevalent Vascular Retinal DiseasesXiaozheng Dou, Adam S Duerfeldt
Chemmedchem|November 18, 2025
Development and Characterization of a Noncovalent Stimulator of Interferon Genes Proteolysis-Targeting ChimerasBo Hu, Adam S Duerfeldt
Journal of the American Chemical Society|January 14, 2014
Total syntheses of (-)-pyrimidoblamic acid and P-3AAdam S Duerfeldt, Dale L Boger
Journal of Medicinal Chemistry|December 22, 2023
Guiding the Way: Traditional Medicinal Chemistry Inspiration for Rational Gram-Negative Drug DesignAlexis M Stoorza, Adam S Duerfeldt
Bioorganic & Medicinal Chemistry Letters|July 27, 2010
Hsp90 inhibition: elimination of shock and stressAdam S Duerfeldt, Brian S J Blagg
ACS Chemical Biology|April 18, 2009
Hydrating for resistance to radicicolAdam S Duerfeldt, Brian S J Blagg
Future Medicinal Chemistry|May 11, 2023
The cGAS-STING pathway in diabetic retinopathy and age-related macular degenerationBo Hu, Jian-Xing Ma, Adam S Duerfeldt
Bioorganic & Medicinal Chemistry Letters|October 22, 2011
Synthesis and biological evaluation of arylated novobiocin analogs as Hsp90 inhibitorsBhaskar Reddy Kusuma, Adam S Duerfeldt, Brian S J Blagg
Bioorganic & Medicinal Chemistry Letters|November 10, 2009
Design, synthesis, and biological activity of bicyclic radester analogues as Hsp90 inhibitorsVinod D Jadhav, Adam S Duerfeldt, Brian S J Blagg
ACS Infectious Diseases|November 10, 2018
Clostridium difficile ClpP Homologues are Capable of Uncoupled Activity and Exhibit Different Levels of Susceptibility to Acyldepsipeptide ModulationNathan P Lavey, Tyler Shadid, Jimmy D Ballard, et al.
Pageof 4